组蛋白甲基转移酶抑制剂对脓毒症小鼠腹腔巨噬细胞极化的影响
该研究将36只雄性C57BL/6J小鼠按随机数字表法分为假手术组(Sham组)、脓毒症模型组(CLP组)和EZH2抑制剂治疗组(CLP+3-DZNeP组),每组12只。CLP+3-DZNeP组于CLP前24小时和CLP后1小时腹腔注射3-DZNeP 1 mg/kg。术后24小时每组处死8只小鼠,检测腹腔灌洗液IL-6、TNF-α水平及腹腔巨噬细胞iNOS、CD206表达,并检测EZH2、PPARγ蛋白表达;术后48小时处死剩余4只小鼠评估肺、肾组织病理改变。结果显示脓毒症诱导腹腔巨噬细胞EZH2高表达、PPARγ低表达及M1型极化增加,3-DZNeP可降低炎症因子水平、减少M1型巨噬细胞比例、增加M2型巨噬细胞比例并减轻肺肾病理改变。
要点
- 脓毒症小鼠腹腔灌洗液IL-6、TNF-α较Sham组显著升高[IL-6(ng/L):7 794.75±405.56 vs. 78.63±74.09,TNF-α(ng/L):147.25±25.19 vs. 18.20±5.03,均P<0.01]。
- CLP组M1型巨噬细胞比例较Sham组显著升高[iNOS+ F4/80+:(13.18±8.80)% vs.(1.57±0.77)%,P<0.05],EZH2蛋白表达升高(EZH2/GAPDH:0.84±0.11 vs. 0.11±0.03,P<0.01),PPARγ蛋白表达降低(PPARγ/GAPDH:0.09±0.01 vs. 0.27±0.09,P<0.01)。
- 3-DZNeP 1 mg/kg于CLP前24小时和CLP后1小时腹腔注射,可使腹腔灌洗液IL-6、TNF-α较CLP组显著降低[IL-6(ng/L):4 207.10±876.60 vs. 7 794.75±405.56,TNF-α(ng/L):63.00±25.37 vs. 147.25±25.19,均P<0.01]。
- 3-DZNeP使M1型巨噬细胞比例较CLP组显著降低[iNOS+ F4/80+:(3.64±0.89)% vs.(13.18±8.80)%,P<0.05],M2型巨噬细胞比例显著升高[CD206+ F4/80+:(17.68±5.63)% vs.(7.60±3.17)%,P<0.01]。
- 3-DZNeP使EZH2蛋白表达较CLP组显著降低(EZH2/GAPDH:0.53±0.09 vs. 0.84±0.11,P<0.05),PPARγ蛋白表达显著升高(PPARγ/GAPDH:0.39±0.14 vs. 0.09±0.01,P<0.05),肺、肾组织病理改变显著减轻。
适用人群与场景
- 健康雄性C57BL/6J小鼠,共36只,按随机数字表法分为Sham组、CLP组和CLP+3-DZNeP组,每组12只。
- 脓毒症动物模型采用盲肠结扎穿孔术(CLP)建立;Sham组仅行盲肠牵拉不结扎。
处置流程与药物剂量
- CLP+3-DZNeP组于CLP前24小时和CLP后1小时腹腔注射3-Deazaneplanocin A(3-DZNeP)1 mg/kg。
- 术后24小时每组处死8只小鼠,用高通量液体蛋白芯片检测腹腔灌洗液IL-6、TNF-α水平,用流式细胞术分析iNOS、CD206表达,用Western Blot检测腹腔巨噬细胞EZH2、PPARγ蛋白表达。
- 术后48小时处死剩余4只小鼠,用苏木精-伊红(HE)染色评估肺、肾组织病理改变。
研究设计与关键结果
- 与Sham组比较,CLP组肺、肾组织炎症细胞浸润,腹腔灌洗液IL-6、TNF-α水平显著升高[IL-6(ng/L):7 794.75±405.56 vs. 78.63±74.09,TNF-α(ng/L):147.25±25.19 vs. 18.20±5.03,均P<0.01],M1型巨噬细胞比例显著升高[iNOS+ F4/80+:(13.18±8.80)% vs.(1.57±0.77)%,P<0.05],EZH2蛋白表达显著升高(EZH2/GAPDH:0.84±0.11 vs. 0.11±0.03,P<0.01),PPARγ蛋白表达显著降低(PPARγ/GAPDH:0.09±0.01 vs. 0.27±0.09,P<0.01)。
- 与CLP组比较,CLP+3-DZNeP组肺、肾组织病理改变显著减轻,腹腔灌洗液IL-6、TNF-α水平显著降低[IL-6(ng/L):4 207.10±876.60 vs. 7 794.75±405.56,TNF-α(ng/L):63.00±25.37 vs. 147.25±25.19,均P<0.01],M1型巨噬细胞比例显著降低[iNOS+ F4/80+:(3.64±0.89)% vs.(13.18±8.80)%,P<0.05],M2型巨噬细胞比例显著升高[CD206+ F4/80+:(17.68±5.63)% vs.(7.60±3.17)%,P<0.01],EZH2蛋白表达显著降低(EZH2/GAPDH:0.53±0.09 vs. 0.84±0.11,P<0.05),PPARγ蛋白表达显著升高(PPARγ/GAPDH:0.39±0.14 vs. 0.09±0.01,P<0.05)。
证据类型、等级与局限
- 动物实验(小鼠脓毒症模型)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,脓毒症诱导腹腔巨噬细胞EZH2高表达,可能通过抑制PPARγ蛋白表达诱导M1型巨噬细胞极化。
- 作者认为,EZH2抑制剂3-DZNeP可通过抑制M1型巨噬细胞极化减少炎症因子释放。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To investigate the effect of histone methyltransferase (EZH2) inhibitor on the polarization of peritoneal macrophages in septic mice.
METHODS: Thirty-six healthy male C57BL/6J mice were divided into three groups by random number table method (n = 12): sham operated group (Sham group), sepsis model group (CLP group) and EZH2 inhibitor treatment group (CLP+3-DZNeP group). Sepsis animal model was established by cecum ligation and puncture (CLP); Sham group was challenged only by cecum traction without ligation. 3-Deazaneplanocin A (3-DZNeP) 1 mg/kg was intraperitoneal injected 24 hours before and 1 hour after CLP in CLP+3-DZNeP group. Eight mice in each group were sacrificed at 24 hours after surgery. The levels of proinflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) in peritoneal lavatory fluid were detected by high throughput liquid protein chip. The expression levels of inducible nitrogenase (iNOS) and macrophage mannose receptor (CD206) were analyzed by flow cytometry. Mouse peritoneal macrophages were isolated and purified by adherent method, the protein expressions of EZH2, peroxisome proliferator-activated receptorγ (PPARγ) were detected by Western Blot. The remaining 4 mice were sacrificed at 48 hours after surgery, the histopathological changes of lung and kidney tissue were evaluated by hematoxylin-eosin (HE) staining.
RESULTS: Compared with Sham group, the infiltration of inflammatory cells in lung and kidney of the CLP group, the levels of IL-6 and TNF-α in peritoneal lavatory fluid were significant increased [IL-6 (ng/L): 7 794.75±405.56 vs. 78.63±74.09, TNF-α (ng/L): 147.25±25.19 vs. 18.20±5.03, both P < 0.01], the percentage of M1 type macrophages was significantly increased [iNOS+ F4/80+: (13.18±8.80)% vs. (1.57±0.77)%, P < 0.05], and the protein expression of EZH2 was significantly increased (EZH2/GAPDH: 0.84±0.11 vs. 0.11±0.03, P < 0.01), while the protein expression of PPARγ was significantly decreased (PPARγ/GAPDH: 0.09±0.01 vs. 0.27±0.09, P < 0.01). Compared with CLP group, the histopathological changes of lung and kidney in CLP+3-DZNeP group were significantly alleviated, the levels of IL-6 and TNF-α in peritoneal lavatory fluid were significantly decreased [IL-6 (ng/L): 4 207.10±876.60 vs. 7 794.75±405.56, TNF-α (ng/L): 63.00±25.37 vs. 147.25±25.19, both P < 0.01 ], the percentage of M1 type macrophages was significantly decreased [iNOS+ F4/80+: (3.64±0.89)% vs. (13.18±8.80)%, P < 0.05], while the percentage of M2 type macrophages was significantly increased [CD206+ F4/80+: (17.68±5.63)% vs. (7.60±3.17)%, P < 0.01], the protein expression of EZH2 was significantly decreased (EZH2/GAPDH: 0.53±0.09 vs. 0.84±0.11, P < 0.05), and the protein expression of PPARγ was significantly increased (PPARγ/GAPDH: 0.39±0.14 vs. 0.09±0.01, P < 0.05).
CONCLUSIONS: Sepsis induces high expression of EZH2 in peritoneal macrophages, and may induce polarization of M1 type macrophages by inhibiting the expression of PPARγ protein. EZH2 inhibitor 3-DZNeP can lessen the inflammatory cytokines release by inhibiting the M1 type macrophages polarization.
参考来源
- Zhang Q, Zhou X, Tang L, et al. [Effects of histone methyltransferase inhibitor on the polarization of peritoneal macrophages in septic mice]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 30827307. doi:10.3760/cma.j.issn.2095-4352.2019.02.013
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。